[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Impact of BMI on In-Hospital Outcomes in Patients with Acute Pancreatitis",
    "section": "",
    "text": "Reference Papers:\n\nSalman et al. 2025\nSingla et al.2009\n\nStudy Objective: Examine the impact of body mass index (BMI) on outcomes among inpatient admissions with Acute Pancreatitis.\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with a primary diagnosis of Acute Pancreatitis.\nBMI Categories:\n\nUnderweight: BMI ≤19.9 kg/m²\nNormal Weight: BMI 20.0 to 24.9 kg/m²\nOverweight: BMI 25.0 to 29.9 kg/m²\nClass I Obesity: BMI 30.0 to 34.9 kg/m²\nClass II Obesity: BMI 35.0 to 39.9 kg/m²\nClass III Obesity: BMI ≥40.0 kg/m²\n\nOutcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nStatistical Analysis: Multiple logistic and linear regression to determine the independent association of BMI categories with in-hospital mortality and length of stay, respectively, adjusted for:\n\nDemographics: Age, sex, race, residential income, and insurance.\nMedical History: Diabetes Mellitus, Hypertension, End stage renal disease, Smoking, Chronic obstructive pulmonary disease, Peripheral vascular disease, Cirrhosis, Atrial fibrillation, Hyperlipidemia, Anemia, Previous myocardial infarction, Previous heart failure\nComorbidities: Charlson comorbidity index.\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Impact of BMI on In-Hospital Outcomes in Patients with Acute Pancreatitis",
    "section": "",
    "text": "Reference Papers:\n\nSalman et al. 2025\nSingla et al.2009\n\nStudy Objective: Examine the impact of body mass index (BMI) on outcomes among inpatient admissions with Acute Pancreatitis.\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with a primary diagnosis of Acute Pancreatitis.\nBMI Categories:\n\nUnderweight: BMI ≤19.9 kg/m²\nNormal Weight: BMI 20.0 to 24.9 kg/m²\nOverweight: BMI 25.0 to 29.9 kg/m²\nClass I Obesity: BMI 30.0 to 34.9 kg/m²\nClass II Obesity: BMI 35.0 to 39.9 kg/m²\nClass III Obesity: BMI ≥40.0 kg/m²\n\nOutcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nStatistical Analysis: Multiple logistic and linear regression to determine the independent association of BMI categories with in-hospital mortality and length of stay, respectively, adjusted for:\n\nDemographics: Age, sex, race, residential income, and insurance.\nMedical History: Diabetes Mellitus, Hypertension, End stage renal disease, Smoking, Chronic obstructive pulmonary disease, Peripheral vascular disease, Cirrhosis, Atrial fibrillation, Hyperlipidemia, Anemia, Previous myocardial infarction, Previous heart failure\nComorbidities: Charlson comorbidity index.\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#baseline-table",
    "href": "quarto/index.html#baseline-table",
    "title": "Impact of BMI on In-Hospital Outcomes in Patients with Acute Pancreatitis",
    "section": "Baseline Table:",
    "text": "Baseline Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall\nN = 183,1851\nNormal weight (BMI 20.0-24.9kg/m²)\nN = 13,9701\nUnderweight (BMI ≤19.9kg/m²)\nN = 20,9451\nOverweight (BMI 25.0-29.9kg/m²)\nN = 18,2951\nClass I obesity (BMI 30.0-34.9kg/m²)\nN = 44,1151\nClass II obesity (BMI 35.0-39.9kg/m²)\nN = 36,9801\nClass III obesity (BMI ≥40.0kg/m²)\nN = 48,8801\np-value2\n\n\n\n\nAge, y\n51 (39, 62)\n55 (43, 66)\n54 (42, 63)\n53 (40, 66)\n52 (39, 62)\n49 (37, 61)\n48 (37, 59)\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Female\n95,555 (52%)\n6,240 (45%)\n10,640 (51%)\n8,405 (46%)\n21,145 (48%)\n18,950 (51%)\n30,175 (62%)\n\n\n\n\n    Male\n87,620 (48%)\n7,725 (55%)\n10,305 (49%)\n9,890 (54%)\n22,970 (52%)\n18,025 (49%)\n18,705 (38%)\n\n\n\n\nRace\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Asian or Pacific Islander\n2,955 (1.7%)\n425 (3.1%)\n440 (2.2%)\n455 (2.5%)\n750 (1.7%)\n460 (1.3%)\n425 (0.9%)\n\n\n\n\n    Black\n30,125 (17%)\n2,375 (17%)\n4,785 (23%)\n2,935 (16%)\n5,965 (14%)\n5,375 (15%)\n8,690 (18%)\n\n\n\n\n    Hispanic\n24,845 (14%)\n1,065 (7.8%)\n1,100 (5.4%)\n2,885 (16%)\n7,545 (17%)\n5,670 (16%)\n6,580 (14%)\n\n\n\n\n    Native American\n1,485 (0.8%)\n65 (0.5%)\n115 (0.6%)\n115 (0.6%)\n330 (0.8%)\n380 (1.1%)\n480 (1.0%)\n\n\n\n\n    Other\n4,925 (2.8%)\n415 (3.1%)\n430 (2.1%)\n565 (3.2%)\n1,200 (2.8%)\n1,185 (3.3%)\n1,130 (2.4%)\n\n\n\n\n    White\n114,640 (64%)\n9,250 (68%)\n13,575 (66%)\n10,935 (61%)\n27,345 (63%)\n23,075 (64%)\n30,460 (64%)\n\n\n\n\nResidential income\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    $1 - $51,999\n58,075 (32%)\n4,150 (30%)\n7,335 (36%)\n5,325 (30%)\n13,075 (30%)\n11,480 (32%)\n16,710 (35%)\n\n\n\n\n    $52,000 - $65,999\n49,180 (27%)\n3,700 (27%)\n5,640 (27%)\n4,675 (26%)\n11,695 (27%)\n10,080 (28%)\n13,390 (28%)\n\n\n\n\n    $66,000 - $87,999\n43,700 (24%)\n3,385 (25%)\n4,525 (22%)\n4,395 (24%)\n10,925 (25%)\n9,195 (25%)\n11,275 (23%)\n\n\n\n\n    $88,000 or more\n29,555 (16%)\n2,490 (18%)\n3,040 (15%)\n3,620 (20%)\n7,845 (18%)\n5,640 (15%)\n6,920 (14%)\n\n\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Medicaid\n44,490 (24%)\n3,945 (28%)\n7,185 (34%)\n4,300 (24%)\n9,620 (22%)\n7,960 (22%)\n11,480 (24%)\n\n\n\n\n    Medicare\n52,155 (29%)\n4,930 (35%)\n7,235 (35%)\n6,005 (33%)\n11,785 (27%)\n9,750 (26%)\n12,450 (25%)\n\n\n\n\n    Other\n21,295 (12%)\n1,645 (12%)\n2,370 (11%)\n2,195 (12%)\n5,600 (13%)\n4,360 (12%)\n5,125 (10%)\n\n\n\n\n    Private\n64,995 (36%)\n3,420 (25%)\n4,125 (20%)\n5,780 (32%)\n17,025 (39%)\n14,875 (40%)\n19,770 (40%)\n\n\n\n\nHospital region\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Midwest\n46,605 (25%)\n3,875 (28%)\n5,925 (28%)\n4,195 (23%)\n10,910 (25%)\n9,230 (25%)\n12,470 (26%)\n\n\n\n\n    Northeast\n28,825 (16%)\n2,300 (16%)\n3,425 (16%)\n3,175 (17%)\n6,895 (16%)\n5,600 (15%)\n7,430 (15%)\n\n\n\n\n    South\n72,065 (39%)\n4,860 (35%)\n8,055 (38%)\n7,065 (39%)\n17,175 (39%)\n14,745 (40%)\n20,165 (41%)\n\n\n\n\n    West\n35,690 (19%)\n2,935 (21%)\n3,540 (17%)\n3,860 (21%)\n9,135 (21%)\n7,405 (20%)\n8,815 (18%)\n\n\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Large\n84,690 (46%)\n6,855 (49%)\n10,580 (51%)\n8,355 (46%)\n19,930 (45%)\n16,555 (45%)\n22,415 (46%)\n\n\n\n\n    Medium\n53,330 (29%)\n4,190 (30%)\n5,710 (27%)\n5,350 (29%)\n13,170 (30%)\n10,670 (29%)\n14,240 (29%)\n\n\n\n\n    Small\n45,165 (25%)\n2,925 (21%)\n4,655 (22%)\n4,590 (25%)\n11,015 (25%)\n9,755 (26%)\n12,225 (25%)\n\n\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Rural\n17,340 (9.5%)\n950 (6.8%)\n1,935 (9.2%)\n1,210 (6.6%)\n3,925 (8.9%)\n3,770 (10%)\n5,550 (11%)\n\n\n\n\n    Urban, non-teaching\n39,525 (22%)\n2,775 (20%)\n3,930 (19%)\n3,840 (21%)\n9,735 (22%)\n8,280 (22%)\n10,965 (22%)\n\n\n\n\n    Urban, teaching\n126,320 (69%)\n10,245 (73%)\n15,080 (72%)\n13,245 (72%)\n30,455 (69%)\n24,930 (67%)\n32,365 (66%)\n\n\n\n\nAdmission type\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n0.001\n\n\n    Elective\n4,355 (2.4%)\n480 (3.4%)\n430 (2.1%)\n525 (2.9%)\n995 (2.3%)\n840 (2.3%)\n1,085 (2.2%)\n\n\n\n\n    Non-elective\n178,740 (98%)\n13,485 (97%)\n20,510 (98%)\n17,765 (97%)\n43,095 (98%)\n36,120 (98%)\n47,765 (98%)\n\n\n\n\nCharlson comorbidity index\n1.00 (0.00, 2.00)\n1.00 (0.00, 2.00)\n1.00 (0.00, 2.00)\n1.00 (0.00, 2.00)\n1.00 (0.00, 2.00)\n1.00 (0.00, 2.00)\n1.00 (0.00, 2.00)\n&lt;0.001\n\n\nDiabetes Mellitus\n67,465 (37%)\n3,105 (22%)\n3,250 (16%)\n6,125 (33%)\n17,280 (39%)\n16,135 (44%)\n21,570 (44%)\n&lt;0.001\n\n\nHypertension\n96,905 (53%)\n6,450 (46%)\n8,690 (41%)\n9,545 (52%)\n24,500 (56%)\n20,795 (56%)\n26,925 (55%)\n&lt;0.001\n\n\nEnd stage renal disease\n2,850 (1.6%)\n305 (2.2%)\n380 (1.8%)\n265 (1.4%)\n575 (1.3%)\n485 (1.3%)\n840 (1.7%)\n0.004\n\n\nSmoking\n44,230 (24%)\n4,985 (36%)\n10,485 (50%)\n4,280 (23%)\n9,405 (21%)\n7,205 (19%)\n7,870 (16%)\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n19,485 (11%)\n1,980 (14%)\n4,170 (20%)\n1,525 (8.3%)\n3,700 (8.4%)\n3,170 (8.6%)\n4,940 (10%)\n&lt;0.001\n\n\nPeripheral vascular disease\n4,205 (2.3%)\n515 (3.7%)\n1,110 (5.3%)\n470 (2.6%)\n930 (2.1%)\n570 (1.5%)\n610 (1.2%)\n&lt;0.001\n\n\nCirrhosis\n6,475 (3.5%)\n870 (6.2%)\n1,370 (6.5%)\n705 (3.9%)\n1,275 (2.9%)\n1,055 (2.9%)\n1,200 (2.5%)\n&lt;0.001\n\n\nAtrial fibrillation\n12,525 (6.8%)\n1,010 (7.2%)\n1,210 (5.8%)\n1,450 (7.9%)\n3,000 (6.8%)\n2,315 (6.3%)\n3,540 (7.2%)\n&lt;0.001\n\n\nHyperlipidemia\n73,195 (40%)\n3,885 (28%)\n3,850 (18%)\n7,450 (41%)\n21,065 (48%)\n17,230 (47%)\n19,715 (40%)\n&lt;0.001\n\n\nAnemia\n36,505 (20%)\n4,875 (35%)\n7,335 (35%)\n4,540 (25%)\n7,365 (17%)\n5,135 (14%)\n7,255 (15%)\n&lt;0.001\n\n\nPrevious myocardial infarction\n6,840 (3.7%)\n470 (3.4%)\n820 (3.9%)\n720 (3.9%)\n1,970 (4.5%)\n1,310 (3.5%)\n1,550 (3.2%)\n&lt;0.001\n\n\nPrevious heart failure\n9,445 (5.2%)\n715 (5.1%)\n1,075 (5.1%)\n745 (4.1%)\n1,960 (4.4%)\n1,780 (4.8%)\n3,170 (6.5%)\n&lt;0.001\n\n\n\n1 Median (Q1, Q3); n (%)\n\n\n2 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment"
  },
  {
    "objectID": "quarto/index.html#outcomes-table",
    "href": "quarto/index.html#outcomes-table",
    "title": "Impact of BMI on In-Hospital Outcomes in Patients with Acute Pancreatitis",
    "section": "Outcomes Table:",
    "text": "Outcomes Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nNormal weight (BMI 20.0-24.9kg/m²)\nN = 13,9701\nUnderweight (BMI ≤19.9kg/m²)\nN = 20,9451\nOverweight (BMI 25.0-29.9kg/m²)\nN = 18,2951\nClass I obesity (BMI 30.0-34.9kg/m²)\nN = 44,1151\nClass II obesity (BMI 35.0-39.9kg/m²)\nN = 36,9801\nClass III obesity (BMI ≥40.0kg/m²)\nN = 48,8801\np-value2\n\n\n\n\nDied during hospitalization\n175 (1.3%)\n210 (1.0%)\n170 (0.9%)\n190 (0.4%)\n185 (0.5%)\n370 (0.8%)\n&lt;0.001\n\n\nLength of stay (days)\n4.0 (3.0, 8.0)\n4.0 (3.0, 6.0)\n4.0 (2.0, 6.0)\n3.0 (2.0, 5.0)\n3.0 (2.0, 5.0)\n3.0 (2.0, 5.0)\n&lt;0.001\n\n\nInflation-adjusted total charge ($)\n35,826 (21,568, 67,725)\n31,236 (18,459, 54,782)\n35,332 (19,751, 66,314)\n31,885 (18,580, 57,076)\n31,335 (18,824, 53,645)\n31,814 (18,677, 55,528)\n&lt;0.001\n\n\n\n1 n (%); Median (Q1, Q3)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test"
  },
  {
    "objectID": "quarto/index.html#multivariable-logistic-regression",
    "href": "quarto/index.html#multivariable-logistic-regression",
    "title": "Impact of BMI on In-Hospital Outcomes in Patients with Acute Pancreatitis",
    "section": "Multivariable Logistic Regression:",
    "text": "Multivariable Logistic Regression:\n\nAll-Cause Mortality:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nBMI category\n\n\n\n\n\n\n\n\n    Normal weight (BMI 20.0-24.9kg/m²)\n—\n—\n\n\n\n\n    Underweight (BMI ≤19.9kg/m²)\n0.90\n0.55, 1.46\n0.7\n\n\n    Overweight (BMI 25.0-29.9kg/m²)\n0.93\n0.56, 1.53\n0.8\n\n\n    Class I obesity (BMI 30.0-34.9kg/m²)\n0.58\n0.35, 0.95\n0.031\n\n\n    Class II obesity (BMI 35.0-39.9kg/m²)\n0.88\n0.52, 1.48\n0.6\n\n\n    Class III obesity (BMI ≥40.0kg/m²)\n1.38\n0.87, 2.20\n0.2\n\n\nAge, y\n1.05\n1.03, 1.06\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n2.09\n1.59, 2.74\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    Asian or Pacific Islander\n—\n—\n\n\n\n\n    Black\n0.81\n0.28, 2.41\n0.7\n\n\n    Hispanic\n0.86\n0.28, 2.65\n0.8\n\n\n    Native American\n2.95\n0.64, 13.5\n0.2\n\n\n    Other\n2.35\n0.71, 7.84\n0.2\n\n\n    White\n1.31\n0.47, 3.67\n0.6\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.65\n0.45, 0.92\n0.015\n\n\n    $66,000 - $87,999\n0.94\n0.66, 1.32\n0.7\n\n\n    $88,000 or more\n0.84\n0.56, 1.24\n0.4\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Medicaid\n—\n—\n\n\n\n\n    Medicare\n0.75\n0.49, 1.17\n0.2\n\n\n    Other\n0.90\n0.50, 1.59\n0.7\n\n\n    Private\n1.00\n0.66, 1.51\n&gt;0.9\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.77\n0.50, 1.17\n0.2\n\n\n    South\n1.03\n0.75, 1.42\n0.8\n\n\n    West\n0.79\n0.52, 1.19\n0.3\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.86\n0.64, 1.16\n0.3\n\n\n    Small\n0.49\n0.34, 0.72\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n2.00\n1.04, 3.84\n0.037\n\n\n    Urban, teaching\n2.28\n1.25, 4.17\n0.007\n\n\nAdmission type\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n3.24\n0.83, 12.7\n0.092\n\n\nCharlson comorbidity index\n1.24\n1.16, 1.33\n&lt;0.001\n\n\nDiabetes Mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.57\n0.41, 0.79\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.84\n0.64, 1.12\n0.2\n\n\nEnd stage renal disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.29\n0.69, 2.38\n0.4\n\n\nSmoking\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.65\n0.44, 0.98\n0.037\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.79\n0.54, 1.15\n0.2\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.22\n0.68, 2.18\n0.5\n\n\nCirrhosis\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.35\n0.84, 2.16\n0.2\n\n\nAtrial fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.88\n1.32, 2.69\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.65\n0.49, 0.88\n0.005\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.05\n1.53, 2.74\n&lt;0.001\n\n\nPrevious myocardial infarction\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.04\n0.62, 1.74\n0.9\n\n\nPrevious heart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.81\n0.51, 1.29\n0.4\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio"
  },
  {
    "objectID": "quarto/index.html#multivariable-linear-regression",
    "href": "quarto/index.html#multivariable-linear-regression",
    "title": "Impact of BMI on In-Hospital Outcomes in Patients with Acute Pancreatitis",
    "section": "Multivariable Linear Regression:",
    "text": "Multivariable Linear Regression:\n\nLength of Stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nBMI category\n\n\n\n\n\n\n\n\n    Normal weight (BMI 20.0-24.9kg/m²)\n—\n—\n\n\n\n\n    Underweight (BMI ≤19.9kg/m²)\n-0.73\n-1.1, -0.39\n&lt;0.001\n\n\n    Overweight (BMI 25.0-29.9kg/m²)\n-0.48\n-0.82, -0.15\n0.004\n\n\n    Class I obesity (BMI 30.0-34.9kg/m²)\n-1.3\n-1.6, -1.1\n&lt;0.001\n\n\n    Class II obesity (BMI 35.0-39.9kg/m²)\n-1.4\n-1.7, -1.1\n&lt;0.001\n\n\n    Class III obesity (BMI ≥40.0kg/m²)\n-1.1\n-1.4, -0.83\n&lt;0.001\n\n\nAge, y\n0.00\n-0.01, 0.00\n0.8\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.49\n0.36, 0.61\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    Asian or Pacific Islander\n—\n—\n\n\n\n\n    Black\n-1.8\n-2.5, -1.1\n&lt;0.001\n\n\n    Hispanic\n-1.2\n-1.9, -0.45\n0.001\n\n\n    Native American\n-0.88\n-1.9, 0.18\n0.10\n\n\n    Other\n-0.73\n-1.6, 0.12\n0.091\n\n\n    White\n-0.96\n-1.7, -0.26\n0.007\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.11\n-0.04, 0.27\n0.2\n\n\n    $66,000 - $87,999\n0.00\n-0.18, 0.17\n&gt;0.9\n\n\n    $88,000 or more\n0.16\n-0.03, 0.34\n0.11\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Medicaid\n—\n—\n\n\n\n\n    Medicare\n-0.16\n-0.37, 0.05\n0.13\n\n\n    Other\n-0.20\n-0.42, 0.01\n0.066\n\n\n    Private\n-0.15\n-0.32, 0.02\n0.094\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.25\n0.04, 0.47\n0.020\n\n\n    South\n0.20\n0.02, 0.38\n0.026\n\n\n    West\n-0.37\n-0.56, -0.18\n&lt;0.001\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-0.75\n-0.91, -0.59\n&lt;0.001\n\n\n    Small\n-1.2\n-1.3, -1.0\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.65\n0.48, 0.83\n&lt;0.001\n\n\n    Urban, teaching\n1.4\n1.2, 1.5\n&lt;0.001\n\n\nAdmission type\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n-0.74\n-1.1, -0.33\n&lt;0.001\n\n\nCharlson comorbidity index\n0.13\n0.08, 0.19\n&lt;0.001\n\n\nDiabetes Mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.08\n-0.22, 0.06\n0.3\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.04\n-0.18, 0.11\n0.6\n\n\nEnd stage renal disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.86\n-0.46, 2.2\n0.2\n\n\nSmoking\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.48\n-0.63, -0.34\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.13\n-0.07, 0.33\n0.2\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.35\n-0.13, 0.83\n0.2\n\n\nCirrhosis\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.55\n0.07, 1.0\n0.023\n\n\nAtrial fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.4\n0.99, 1.7\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.34\n-0.47, -0.21\n&lt;0.001\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.6\n2.4, 2.9\n&lt;0.001\n\n\nPrevious myocardial infarction\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.66\n-0.94, -0.39\n&lt;0.001\n\n\nPrevious heart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.21\n-0.50, 0.08\n0.2\n\n\n\nAbbreviation: CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nInflation Adjusted Total Charge:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nBMI category\n\n\n\n\n\n\n\n\n    Normal weight (BMI 20.0-24.9kg/m²)\n—\n—\n\n\n\n\n    Underweight (BMI ≤19.9kg/m²)\n-5,539\n-9,893, -1,184\n0.013\n\n\n    Overweight (BMI 25.0-29.9kg/m²)\n586\n-3,579, 4,751\n0.8\n\n\n    Class I obesity (BMI 30.0-34.9kg/m²)\n-5,932\n-9,495, -2,370\n0.001\n\n\n    Class II obesity (BMI 35.0-39.9kg/m²)\n-5,165\n-8,796, -1,534\n0.005\n\n\n    Class III obesity (BMI ≥40.0kg/m²)\n-333\n-4,394, 3,729\n0.9\n\n\nAge, y\n45\n-33, 123\n0.3\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n6,269\n4,445, 8,092\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    Asian or Pacific Islander\n—\n—\n\n\n\n\n    Black\n-29,287\n-40,328, -18,246\n&lt;0.001\n\n\n    Hispanic\n-11,868\n-23,143, -593\n0.039\n\n\n    Native American\n-25,122\n-40,468, -9,777\n0.001\n\n\n    Other\n-8,508\n-21,570, 4,554\n0.2\n\n\n    White\n-19,075\n-30,064, -8,085\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-607\n-2,839, 1,624\n0.6\n\n\n    $66,000 - $87,999\n-1,385\n-4,192, 1,421\n0.3\n\n\n    $88,000 or more\n3,013\n-260, 6,285\n0.071\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Medicaid\n—\n—\n\n\n\n\n    Medicare\n-121\n-2,947, 2,705\n&gt;0.9\n\n\n    Other\n4,098\n835, 7,362\n0.014\n\n\n    Private\n2,852\n499, 5,205\n0.018\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n8,933\n5,683, 12,182\n&lt;0.001\n\n\n    South\n9,226\n6,726, 11,726\n&lt;0.001\n\n\n    West\n20,963\n17,443, 24,482\n&lt;0.001\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-7,848\n-10,467, -5,229\n&lt;0.001\n\n\n    Small\n-14,222\n-16,652, -11,791\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n17,792\n15,245, 20,338\n&lt;0.001\n\n\n    Urban, teaching\n22,761\n20,716, 24,806\n&lt;0.001\n\n\nAdmission type\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n-5,297\n-10,443, -152\n0.044\n\n\nCharlson comorbidity index\n1,210\n424, 1,997\n0.003\n\n\nDiabetes Mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1,359\n-3,709, 991\n0.3\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1,385\n-3,594, 824\n0.2\n\n\nEnd stage renal disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n31,185\n4,038, 58,332\n0.024\n\n\nSmoking\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-9,353\n-11,134, -7,571\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1,152\n-1,340, 3,644\n0.4\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2,810\n-3,972, 9,592\n0.4\n\n\nCirrhosis\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n8,540\n728, 16,351\n0.032\n\n\nAtrial fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n18,169\n11,842, 24,496\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-4,716\n-6,593, -2,839\n&lt;0.001\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n29,697\n26,200, 33,193\n&lt;0.001\n\n\nPrevious myocardial infarction\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-6,875\n-10,894, -2,856\n&lt;0.001\n\n\nPrevious heart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-5,769\n-9,735, -1,802\n0.004\n\n\n\nAbbreviation: CI = Confidence Interval"
  }
]